Literature DB >> 24120536

Epidemiological features of Kawasaki disease in Taiwan, 1976-2007: results of five nationwide questionnaire hospital surveys.

Hung-Chi Lue1, Lei-Ru Chen2, Ming-Tai Lin2, Luan-Yin Chang2, Jou-Kou Wang2, Chin-Yun Lee2, Mei-Hwan Wu2.   

Abstract

BACKGROUND: Kawasaki disease (KD) affects mainly children younger than 5 years of age, leading to coronary artery lesions, and even to life-threatening myocardial infarction. In Taiwan, KD was encountered for the first time in 1976; then, it continued to occur in increasing numbers.
METHODS: For the survey of epidemiological features of KD in Taiwan, we conducted five nationwide questionnaire hospital surveys in 1987, 1992, 1994, 2001, and 2008, respectively. In each survey, a special questionnaire form, together with a request letter and diagnostic guidelines for KD, was sent to the chairman of the Department of Pediatrics of all hospitals with 100 or more beds in Taiwan.
RESULTS: KD patients increased to a total of 14,399 patients by 2007, with the highest number of 1018 in 2001, and the highest incidence of 66.24 per 100,000 children < 5 years of age in 2006. Of the 14,399 patients, the male-to-female ratio ranged from 1.5 to 1.7. Of these patients, 57.6-65.2% were < 2 years of age, 23.3-26.6% were 2-4 years of age, and 11.4-15.8% were ≥ 5 years of age. Coronary artery lesions were noted in 20.2-31.5% of patients. Fourteen cases expired, documenting that the fatality rate decreased from 0.4% to 0.03% during the 31 years from 1976 to 2007.
CONCLUSION: In Taiwan, KD was encountered for the first time in 1976, and it continued to occur, reaching the highest annual incidence of 66.24 per 100,000 children < 5 years of age in 2006. In Taiwan, the first emergence of KD came in 1976; the annual increment of the incidence rate was lower (2.41 in Taiwan vs. 4.17 Japan), and no significant KD outbreak was observed in Taiwan.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  Kawasaki disease; Taiwan; annual incidence; children; coronary artery aneurysm; epidemiology; questionnaire hospital surveys

Mesh:

Year:  2013        PMID: 24120536     DOI: 10.1016/j.pedneo.2013.07.010

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  13 in total

1.  Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.

Authors:  Qian Peng; Yan Deng; Xiling Yang; Xiangyou Leng; Yuan Yang; Hanmin Liu
Journal:  Eur J Pediatr       Date:  2016-02-01       Impact factor: 3.183

2.  Systemic inflammatory syndrome in COVID-19-SISCoV study: systematic review and meta-analysis.

Authors:  Debjyoti Dhar; Treshita Dey; M M Samim; Hansashree Padmanabha; Aritra Chatterjee; Parvin Naznin; S R Chandra; K Mallesh; Rutul Shah; Shahyan Siddiqui; K Pratik; P Ameya; G Abhishek
Journal:  Pediatr Res       Date:  2021-05-18       Impact factor: 3.953

3.  The roles of Ca2+/NFAT signaling genes in Kawasaki disease: single- and multiple-risk genetic variants.

Authors:  Wei Wang; Jiao Lou; Rong Zhong; Yan-qi Qi; Na Shen; Xu-zai Lu; Yu-jia Wang; Qing Zhang; Li Zou; Jia-yu Duan; Jun-tao Ke; Xiao-ping Miao; Fang-qi Gong
Journal:  Sci Rep       Date:  2014-06-06       Impact factor: 4.379

4.  Systematic confirmation study of GWAS-identified genetic variants for Kawasaki disease in a Chinese population.

Authors:  Jiao Lou; Rong Zhong; Na Shen; Xu-zai Lu; Jun-tao Ke; Jia-yu Duan; Yan-qi Qi; Yu-jia Wang; Qing Zhang; Wei Wang; Fang-qi Gong; Xiao-ping Miao
Journal:  Sci Rep       Date:  2015-02-03       Impact factor: 4.379

Review 5.  Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.

Authors:  Alessandra Marchesi; Isabella Tarissi de Jacobis; Donato Rigante; Alessandro Rimini; Walter Malorni; Giovanni Corsello; Grazia Bossi; Sabrina Buonuomo; Fabio Cardinale; Elisabetta Cortis; Fabrizio De Benedetti; Andrea De Zorzi; Marzia Duse; Domenico Del Principe; Rosa Maria Dellepiane; Livio D'Isanto; Maya El Hachem; Susanna Esposito; Fernanda Falcini; Ugo Giordano; Maria Cristina Maggio; Savina Mannarino; Gianluigi Marseglia; Silvana Martino; Giulia Marucci; Rossella Massaro; Christian Pescosolido; Donatella Pietraforte; Maria Cristina Pietrogrande; Patrizia Salice; Aurelio Secinaro; Elisabetta Straface; Alberto Villani
Journal:  Ital J Pediatr       Date:  2018-08-30       Impact factor: 2.638

6.  The IL-1B Gene Polymorphisms rs16944 and rs1143627 Contribute to an Increased Risk of Coronary Artery Lesions in Southern Chinese Children with Kawasaki Disease.

Authors:  Lan Yan Fu; Xiantao Qiu; Qiu Lian Deng; Ping Huang; Lei Pi; Yufen Xu; Di Che; Huazhong Zhou; Zhaoliang Lu; Yaqian Tan; Zhiyong Jiang; Li Zhang; Techang Liu; Xiaoqiong Gu
Journal:  J Immunol Res       Date:  2019-04-09       Impact factor: 4.818

7.  Changing Spectrum of Cardiac Diseases in Children: An Extended Longitudinal Observation Study of a Pediatric Cardiac Screening Program.

Authors:  Chun-Min Fu; Jou-Kou Wang; Mei-Hwan Wu; Yu-Chuan Hua; Shuenn-Nan Chiu; Ming-Tai Lin; Chun-An Chen; Hung-Chi Lue
Journal:  Acta Cardiol Sin       Date:  2021-07       Impact factor: 2.672

8.  8p22-23-rs2254546 as a susceptibility locus for Kawasaki disease: a case-control study and a meta-analysis.

Authors:  Wei Wang; Jiao Lou; Xu-zai Lu; Yan-qi Qi; Na Shen; Rong Zhong; Yu-jia Wang; Li Zou; Qing Zhang; Jia-yu Duan; Jun-tao Ke; Xiao-ping Miao; Fang-qi Gong
Journal:  Sci Rep       Date:  2014-02-28       Impact factor: 4.379

9.  Ethnic Kawasaki Disease Risk Associated with Blood Mercury and Cadmium in U.S. Children.

Authors:  Deniz Yeter; Michael A Portman; Michael Aschner; Marcelo Farina; Wen-Ching Chan; Kai-Sheng Hsieh; Ho-Chang Kuo
Journal:  Int J Environ Res Public Health       Date:  2016-01-05       Impact factor: 3.390

10.  Serum exosomal miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy.

Authors:  Xiaofei Zhang; Guangda Xin; Dajun Sun
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.